Max Robotics — Global Service Robot Directory + US Certification

About

Meagan Costedio is a colorectal surgeon and clinical researcher whose work sits at the intersection of minimally invasive surgery, surgical oncology, and value-based healthcare. She has made significant contributions to advancing the understanding of robotic and laparoscopic approaches in colorectal surgery, with a particular focus on rectal cancer and inflammatory bowel disease. Costedio's most influential work, "Considering Value in Rectal Cancer Surgery" (2016, 88 citations), tackled a critical question in the era of value-based medicine: whether the higher costs of robotic proctectomy are justified by improved patient outcomes compared to open and laparoscopic alternatives. Her research has consistently examined how surgical approach affects perioperative outcomes across diverse patient populations, including a notable study demonstrating the potential advantages of robotic surgery in technically challenging obese patients (67 citations). Beyond rectal cancer, Costedio extended her comparative analyses to inflammatory bowel disease, colectomy outcomes using national registry data, and practical surgical concerns such as stoma site complications and robotic system malfunctions. Her longitudinal body of work — spanning from early institutional comparisons to recent population-level trend analyses — has helped shape evidence-based adoption of robotic colorectal surgery, making her a meaningful voice in the ongoing evolution of surgical technique and healthcare value optimization.